Breaking News

BioXcel and Takeda Partner

Will repurpose assets for orphan diseases

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioXcel Corporation, a provider of cloud-based Pharma big data solutions for discovering novel products, has entered into a partnership with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases. Through this partnership, Takeda, a global research-based company with a focus on innovation in medicine, will gain access to and leverage BioXcel’s Big Data Innovation Lab, an integrated product discovery engine, and PharmGPS Orphan Disease Suite for d...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters